BioSpace News Archive

Specific financial terms of the agreement have not been disclosed.

Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided 2018 highlights, 2019 guidance and commercialization plans for INBRIJA at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco.

Wellness incentives and fitness amenities are most commonly sought by employees and provided by companies

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive data from the open-label extension (OLE) of the Phase 2 OASIS trial of its investigational drug candidate etrasimod, a next-generation, oral, selective sphingosine 1 phosphate (S1P) receptor modulator in development for the treatment of moderate to severely active ulcerative colitis (UC).

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced preliminary unaudited revenue results for the fourth quarter and full year 2018.

Mirati Therapeutics, Inc. (NASDAQ: MRTX) a clinical-stage targeted oncology company, today announced a clinical collaboration with Bristol-Myers Squibb Company to evaluate the combination of sitravatinib and nivolumab (OPDIVO®), in Mirati’s planned Phase 3 trial in second line non-small cell lung cancer (NSCLC) patients who have progressed following treatment with a platinum-based regimen and a checkpoint inhibitor.

Global biotechnology giant CSL Limited announced that it will present at the 2019 J.P. Morgan Annual Healthcare Conference.

Harley Ellis Devereaux (HED) and Walsh Construction are pleased to announce the successful completion of the new Palos Health South Campus in the Chicago suburb of Orland Park, IL.

Preliminary, unaudited revenue for fourth quarter 2018 is expected to be approximately $52.9 million, reflecting growth of approximately 15% over the fourth quarter of 2017.

OSI Systems, Inc. announced that its Rapiscan RTT® 110 CT inspection system has recently been selected by the Australian government to identify contraband biosecurity materials entering the country inside passenger baggage, mail, and cargo.